Single Cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib
Ontology highlight
ABSTRACT: Single Cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib
PROVIDER: PRJNA782728 | ENA |
REPOSITORIES: ENA
ACCESS DATA